# OnCo record allogeneic-hsct (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/allogeneic-hsct/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "allogeneic-hsct" ;
  schema:name "Allogeneic stem cell transplantation"@en ;
  schema:description "Allogeneic stem cell transplantation replaces a patient's blood system with a donor's after conditioning chemotherapy, so donor immune cells hunt down leukaemia left behind. It remains the only cure for adverse-risk acute myeloid leukaemia, high-risk acute lymphoblastic leukaemia and Richter transformation, at the price of graft-versus-host disease."@en ;
  schema:url <https://onco.cc/technologies/allogeneic-hsct/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1128050> ;
  schema:citation <https://en.wikipedia.org/wiki/Hematopoietic_stem_cell_transplantation> ;
  onco:status "standard-of-care" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/cll/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/> ;
  onco:technologies <https://onco.cc/technologies/mrd-testing/> ;
  onco:drugs <https://onco.cc/drugs/defibrotide/> ;
  onco:companies <https://onco.cc/companies/vor-biopharma/> ;
  onco:terms <https://onco.cc/terms/mrd-negative-cr/>, <https://onco.cc/terms/eln-risk/> ;
  onco:journals <https://onco.cc/journals/hematology-oncology-and-stem-cell-therapy/> .